dr. G.W. van Imhoff

Research

  1. 2019
  2. Rigter, L. S., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., Roesink, J., ... van Leerdam, M. E. (2019). Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer. Cancer medicine, 8(1), 190-199. https://doi.org/10.1002/cam4.1922
  3. 2018
  4. Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., ... Veelken, H. (2018). Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Annals of Hematology, 97(2), 255-266. https://doi.org/10.1007/s00277-017-3167-7
  5. 2017
  6. 2016
  7. Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., ... Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica, 101(10), E407-E410. [407]. https://doi.org/10.3324/haematol.2016.146977
  8. 2015
  9. Schaapveld, M., Aleman, B. M. P., van Eggermond, A. M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., ... van Leeuwen, F. E. (2015). Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. New England Journal of Medicine, 373(26), 2499-2511. https://doi.org/10.1056/NEJMoa1505949
  10. Nijland, M., Boslooper, K., Van den Berg, A., Kluin-Nelemans, H. C., Joosten, P., Storm, H., ... Hoogendoorn, M. (2015). Impact of Radiotherapy and Rituximab on Outcome of Stage I(E) Diffuse Large B-Cell Lymphoma. Blood, 126(23).
  11. te Boome, L. C. J., Mansilla, C., van der Wagen, L. E., Lindemans, C. A., Petersen, E. J., Spierings, E., ... Kuball, J. (2015). Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. Leukemia, 29(9), 1839-1846. https://doi.org/10.1038/leu.2015.89
  12. 2014
  13. 2013
  14. Vos, J. M. I., Minnema, M. C., Wijermans, P. W., Croockewit, S., Chamuleau, M. E. D., Pals, S. T., ... HOVON Lymphoma Working Party (2013). Guideline for diagnosis and treatment of Waldenstrom's macroglobulinaemia. Netherlands Journal of Medicine, 71(2), 54-62.
  15. 2012
  16. 2011
  17. Noordzij, W., Weernink, E. E. M., Van Imhoff, G. W., Kluin, P. M., & De Haan, L. D. (2011). Benigne histiocytose: ziekte van Rosai-Dorfman. Nederlands Tijdschrift voor Geneeskunde, 155(27), 1219-1223.
  18. Kluin-Nelemans, H. C., Kooy, M. V. M., Lugtenburg, P. J., van Putten, W. L. J., Luten, M., Oudejans, J., & van Imhoff, G. W. (2011). Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma. Annals of Oncology, 22(7), 1595-1600. https://doi.org/10.1093/annonc/mdq635
  19. 2010
  20. Schuurmans, M., Bromberg, J. E. C., Doorduijn, J., Poortmans, P., Taphoorn, M. J. B., Seute, T., ... van den Bent, M. J. (2010). Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis. British Journal of Haematology, 151(2), 179-184. https://doi.org/10.1111/j.1365-2141.2010.08328.x
  21. 2009
Previous 1 2 3 Next

ID: 91256